ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Theraputic Drug Monitorings Market Research Report 2024
Published Date: February 2024
|
Report Code: QYRE-Auto-21E13406
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Theraputic Drug Monitorings Market Research Report 2023
BUY CHAPTERS

Global Theraputic Drug Monitorings Market Research Report 2024

Code: QYRE-Auto-21E13406
Report
February 2024
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Siemens Healthineers
Thermo Fisher Scientific
Beckman Coulter
Agilent Technologies
bioMérieux
SEKISUI Medical
DiaSorin
Fujirebio
Grifols S A
Ortho Clinical Diagnostics
Quest Diagnostics
Sysmex
Tosoh
Chromsystems
Bio Rad
R-Biopharm AG
ALPCO
BIOHIT Healthcare
MedTox
Wieslab
ARK Diagnostics
Probe Scientific
Omnica

Theraputic Drug Monitorings Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Theraputic Drug Monitorings Market

Theraputic Drug Monitorings Market

Therapeutic drug monitoring is the measurement of specific drugs at timed intervals in order to maintain a relatively constant concentration of the medication in the blood. Monitored drugs tend to have a narrow "therapeutic index," – the difference between the toxic and therapeutic doses of medications. For some drugs, maintaining this steady concentration in the blood is not as simple as giving a standard dose of medication to everyone. Each person will absorb, metabolise, utilise, and eliminate drugs at different rates based upon their age, general state of health, genetic makeup, and the influence of other medications that they are taking. These factors may change over time and vary from day to day or with various disease states.
The global Theraputic Drug Monitorings market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Theraputic Drug Monitorings, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Theraputic Drug Monitorings.

Report Scope

The Theraputic Drug Monitorings market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Theraputic Drug Monitorings market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Theraputic Drug Monitorings companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Theraputic Drug Monitorings Market Report

Report Metric Details
Report Name Theraputic Drug Monitorings Market
CAGR 5%
Segment by Type
  • Chemiluminescence Immunoassay (CLIA)
  • Fluorescence Immunoassay (FPIA)
  • Radioimmunoassay (RIA)
  • Colorimetric Immunoassay
  • Other Immunoassays
Segment by Application
  • Antiepileptic Drugs
  • Immunosuppressant
  • Antitumor Drugs
  • Psychotropic Drugs
  • Antibiotic
  • Antifungal
  • Cardiovascular Drugs
  • Antiasthmatic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche AG, Siemens Healthineers, Thermo Fisher Scientific, Beckman Coulter, Agilent Technologies, BioMérieux, Sekisui Medical, DiaSorin, Fujirebio, Grifols, Ortho-Clinical Diagnostics, Quest Diagnostics, Sysmex, Tosoh, Chromsystems, Bio-Rad, R-Biopharm AG, ALPCO, BIOHIT Healthcare, MedTox, Wieslab, ARK Diagnostics, Probe Scientific, Omnica
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Theraputic Drug Monitorings companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Theraputic Drug Monitorings Market report?

Ans: The main players in the Theraputic Drug Monitorings Market are Roche AG, Siemens Healthineers, Thermo Fisher Scientific, Beckman Coulter, Agilent Technologies, BioMérieux, Sekisui Medical, DiaSorin, Fujirebio, Grifols, Ortho-Clinical Diagnostics, Quest Diagnostics, Sysmex, Tosoh, Chromsystems, Bio-Rad, R-Biopharm AG, ALPCO, BIOHIT Healthcare, MedTox, Wieslab, ARK Diagnostics, Probe Scientific, Omnica

What are the Application segmentation covered in the Theraputic Drug Monitorings Market report?

Ans: The Applications covered in the Theraputic Drug Monitorings Market report are Antiepileptic Drugs, Immunosuppressant, Antitumor Drugs, Psychotropic Drugs, Antibiotic, Antifungal, Cardiovascular Drugs, Antiasthmatic, Others

What are the Type segmentation covered in the Theraputic Drug Monitorings Market report?

Ans: The Types covered in the Theraputic Drug Monitorings Market report are Chemiluminescence Immunoassay (CLIA), Fluorescence Immunoassay (FPIA), Radioimmunoassay (RIA), Colorimetric Immunoassay, Other Immunoassays

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Theraputic Drug Monitorings Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Chemiluminescence Immunoassay (CLIA)
1.2.3 Fluorescence Immunoassay (FPIA)
1.2.4 Radioimmunoassay (RIA)
1.2.5 Colorimetric Immunoassay
1.2.6 Other Immunoassays
1.3 Market by Application
1.3.1 Global Theraputic Drug Monitorings Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Antiepileptic Drugs
1.3.3 Immunosuppressant
1.3.4 Antitumor Drugs
1.3.5 Psychotropic Drugs
1.3.6 Antibiotic
1.3.7 Antifungal
1.3.8 Cardiovascular Drugs
1.3.9 Antiasthmatic
1.3.10 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Theraputic Drug Monitorings Market Perspective (2019-2030)
2.2 Theraputic Drug Monitorings Growth Trends by Region
2.2.1 Global Theraputic Drug Monitorings Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Theraputic Drug Monitorings Historic Market Size by Region (2019-2024)
2.2.3 Theraputic Drug Monitorings Forecasted Market Size by Region (2025-2030)
2.3 Theraputic Drug Monitorings Market Dynamics
2.3.1 Theraputic Drug Monitorings Industry Trends
2.3.2 Theraputic Drug Monitorings Market Drivers
2.3.3 Theraputic Drug Monitorings Market Challenges
2.3.4 Theraputic Drug Monitorings Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Theraputic Drug Monitorings Players by Revenue
3.1.1 Global Top Theraputic Drug Monitorings Players by Revenue (2019-2024)
3.1.2 Global Theraputic Drug Monitorings Revenue Market Share by Players (2019-2024)
3.2 Global Theraputic Drug Monitorings Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Theraputic Drug Monitorings Revenue
3.4 Global Theraputic Drug Monitorings Market Concentration Ratio
3.4.1 Global Theraputic Drug Monitorings Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Theraputic Drug Monitorings Revenue in 2023
3.5 Theraputic Drug Monitorings Key Players Head office and Area Served
3.6 Key Players Theraputic Drug Monitorings Product Solution and Service
3.7 Date of Enter into Theraputic Drug Monitorings Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Theraputic Drug Monitorings Breakdown Data by Type
4.1 Global Theraputic Drug Monitorings Historic Market Size by Type (2019-2024)
4.2 Global Theraputic Drug Monitorings Forecasted Market Size by Type (2025-2030)
5 Theraputic Drug Monitorings Breakdown Data by Application
5.1 Global Theraputic Drug Monitorings Historic Market Size by Application (2019-2024)
5.2 Global Theraputic Drug Monitorings Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Theraputic Drug Monitorings Market Size (2019-2030)
6.2 North America Theraputic Drug Monitorings Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Theraputic Drug Monitorings Market Size by Country (2019-2024)
6.4 North America Theraputic Drug Monitorings Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Theraputic Drug Monitorings Market Size (2019-2030)
7.2 Europe Theraputic Drug Monitorings Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Theraputic Drug Monitorings Market Size by Country (2019-2024)
7.4 Europe Theraputic Drug Monitorings Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Theraputic Drug Monitorings Market Size (2019-2030)
8.2 Asia-Pacific Theraputic Drug Monitorings Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Theraputic Drug Monitorings Market Size by Region (2019-2024)
8.4 Asia-Pacific Theraputic Drug Monitorings Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Theraputic Drug Monitorings Market Size (2019-2030)
9.2 Latin America Theraputic Drug Monitorings Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Theraputic Drug Monitorings Market Size by Country (2019-2024)
9.4 Latin America Theraputic Drug Monitorings Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Theraputic Drug Monitorings Market Size (2019-2030)
10.2 Middle East & Africa Theraputic Drug Monitorings Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Theraputic Drug Monitorings Market Size by Country (2019-2024)
10.4 Middle East & Africa Theraputic Drug Monitorings Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche AG
11.1.1 Roche AG Company Detail
11.1.2 Roche AG Business Overview
11.1.3 Roche AG Theraputic Drug Monitorings Introduction
11.1.4 Roche AG Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.1.5 Roche AG Recent Development
11.2 Siemens Healthineers
11.2.1 Siemens Healthineers Company Detail
11.2.2 Siemens Healthineers Business Overview
11.2.3 Siemens Healthineers Theraputic Drug Monitorings Introduction
11.2.4 Siemens Healthineers Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.2.5 Siemens Healthineers Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Theraputic Drug Monitorings Introduction
11.3.4 Thermo Fisher Scientific Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Detail
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter Theraputic Drug Monitorings Introduction
11.4.4 Beckman Coulter Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.4.5 Beckman Coulter Recent Development
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Detail
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies Theraputic Drug Monitorings Introduction
11.5.4 Agilent Technologies Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.5.5 Agilent Technologies Recent Development
11.6 BioMérieux
11.6.1 BioMérieux Company Detail
11.6.2 BioMérieux Business Overview
11.6.3 BioMérieux Theraputic Drug Monitorings Introduction
11.6.4 BioMérieux Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.6.5 BioMérieux Recent Development
11.7 Sekisui Medical
11.7.1 Sekisui Medical Company Detail
11.7.2 Sekisui Medical Business Overview
11.7.3 Sekisui Medical Theraputic Drug Monitorings Introduction
11.7.4 Sekisui Medical Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.7.5 Sekisui Medical Recent Development
11.8 DiaSorin
11.8.1 DiaSorin Company Detail
11.8.2 DiaSorin Business Overview
11.8.3 DiaSorin Theraputic Drug Monitorings Introduction
11.8.4 DiaSorin Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.8.5 DiaSorin Recent Development
11.9 Fujirebio
11.9.1 Fujirebio Company Detail
11.9.2 Fujirebio Business Overview
11.9.3 Fujirebio Theraputic Drug Monitorings Introduction
11.9.4 Fujirebio Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.9.5 Fujirebio Recent Development
11.10 Grifols
11.10.1 Grifols Company Detail
11.10.2 Grifols Business Overview
11.10.3 Grifols Theraputic Drug Monitorings Introduction
11.10.4 Grifols Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.10.5 Grifols Recent Development
11.11 Ortho-Clinical Diagnostics
11.11.1 Ortho-Clinical Diagnostics Company Detail
11.11.2 Ortho-Clinical Diagnostics Business Overview
11.11.3 Ortho-Clinical Diagnostics Theraputic Drug Monitorings Introduction
11.11.4 Ortho-Clinical Diagnostics Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.11.5 Ortho-Clinical Diagnostics Recent Development
11.12 Quest Diagnostics
11.12.1 Quest Diagnostics Company Detail
11.12.2 Quest Diagnostics Business Overview
11.12.3 Quest Diagnostics Theraputic Drug Monitorings Introduction
11.12.4 Quest Diagnostics Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.12.5 Quest Diagnostics Recent Development
11.13 Sysmex
11.13.1 Sysmex Company Detail
11.13.2 Sysmex Business Overview
11.13.3 Sysmex Theraputic Drug Monitorings Introduction
11.13.4 Sysmex Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.13.5 Sysmex Recent Development
11.14 Tosoh
11.14.1 Tosoh Company Detail
11.14.2 Tosoh Business Overview
11.14.3 Tosoh Theraputic Drug Monitorings Introduction
11.14.4 Tosoh Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.14.5 Tosoh Recent Development
11.15 Chromsystems
11.15.1 Chromsystems Company Detail
11.15.2 Chromsystems Business Overview
11.15.3 Chromsystems Theraputic Drug Monitorings Introduction
11.15.4 Chromsystems Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.15.5 Chromsystems Recent Development
11.16 Bio-Rad
11.16.1 Bio-Rad Company Detail
11.16.2 Bio-Rad Business Overview
11.16.3 Bio-Rad Theraputic Drug Monitorings Introduction
11.16.4 Bio-Rad Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.16.5 Bio-Rad Recent Development
11.17 R-Biopharm AG
11.17.1 R-Biopharm AG Company Detail
11.17.2 R-Biopharm AG Business Overview
11.17.3 R-Biopharm AG Theraputic Drug Monitorings Introduction
11.17.4 R-Biopharm AG Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.17.5 R-Biopharm AG Recent Development
11.18 ALPCO
11.18.1 ALPCO Company Detail
11.18.2 ALPCO Business Overview
11.18.3 ALPCO Theraputic Drug Monitorings Introduction
11.18.4 ALPCO Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.18.5 ALPCO Recent Development
11.19 BIOHIT Healthcare
11.19.1 BIOHIT Healthcare Company Detail
11.19.2 BIOHIT Healthcare Business Overview
11.19.3 BIOHIT Healthcare Theraputic Drug Monitorings Introduction
11.19.4 BIOHIT Healthcare Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.19.5 BIOHIT Healthcare Recent Development
11.20 MedTox
11.20.1 MedTox Company Detail
11.20.2 MedTox Business Overview
11.20.3 MedTox Theraputic Drug Monitorings Introduction
11.20.4 MedTox Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.20.5 MedTox Recent Development
11.21 Wieslab
11.21.1 Wieslab Company Detail
11.21.2 Wieslab Business Overview
11.21.3 Wieslab Theraputic Drug Monitorings Introduction
11.21.4 Wieslab Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.21.5 Wieslab Recent Development
11.22 ARK Diagnostics
11.22.1 ARK Diagnostics Company Detail
11.22.2 ARK Diagnostics Business Overview
11.22.3 ARK Diagnostics Theraputic Drug Monitorings Introduction
11.22.4 ARK Diagnostics Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.22.5 ARK Diagnostics Recent Development
11.23 Probe Scientific
11.23.1 Probe Scientific Company Detail
11.23.2 Probe Scientific Business Overview
11.23.3 Probe Scientific Theraputic Drug Monitorings Introduction
11.23.4 Probe Scientific Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.23.5 Probe Scientific Recent Development
11.24 Omnica
11.24.1 Omnica Company Detail
11.24.2 Omnica Business Overview
11.24.3 Omnica Theraputic Drug Monitorings Introduction
11.24.4 Omnica Revenue in Theraputic Drug Monitorings Business (2019-2024)
11.24.5 Omnica Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Roche
Siemens Healthineers
Thermo Fisher Scientific
Beckman Coulter
Agilent Technologies
bioMérieux
SEKISUI Medical
DiaSorin
Fujirebio
Grifols S A
Ortho Clinical Diagnostics
Quest Diagnostics
Sysmex
Tosoh
Chromsystems
Bio Rad
R-Biopharm AG
ALPCO
BIOHIT Healthcare
MedTox
Wieslab
ARK Diagnostics
Probe Scientific
Omnica
List of Tables
    Table 1. Global Theraputic Drug Monitorings Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Chemiluminescence Immunoassay (CLIA)
    Table 3. Key Players of Fluorescence Immunoassay (FPIA)
    Table 4. Key Players of Radioimmunoassay (RIA)
    Table 5. Key Players of Colorimetric Immunoassay
    Table 6. Key Players of Other Immunoassays
    Table 7. Global Theraputic Drug Monitorings Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Theraputic Drug Monitorings Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Theraputic Drug Monitorings Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Theraputic Drug Monitorings Market Share by Region (2019-2024)
    Table 11. Global Theraputic Drug Monitorings Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Theraputic Drug Monitorings Market Share by Region (2025-2030)
    Table 13. Theraputic Drug Monitorings Market Trends
    Table 14. Theraputic Drug Monitorings Market Drivers
    Table 15. Theraputic Drug Monitorings Market Challenges
    Table 16. Theraputic Drug Monitorings Market Restraints
    Table 17. Global Theraputic Drug Monitorings Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Theraputic Drug Monitorings Market Share by Players (2019-2024)
    Table 19. Global Top Theraputic Drug Monitorings Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Theraputic Drug Monitorings as of 2023)
    Table 20. Ranking of Global Top Theraputic Drug Monitorings Companies by Revenue (US$ Million) in 2023
    Table 21. Global 5 Largest Players Market Share by Theraputic Drug Monitorings Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Theraputic Drug Monitorings Product Solution and Service
    Table 24. Date of Enter into Theraputic Drug Monitorings Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Theraputic Drug Monitorings Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Theraputic Drug Monitorings Revenue Market Share by Type (2019-2024)
    Table 28. Global Theraputic Drug Monitorings Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Theraputic Drug Monitorings Revenue Market Share by Type (2025-2030)
    Table 30. Global Theraputic Drug Monitorings Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Theraputic Drug Monitorings Revenue Market Share by Application (2019-2024)
    Table 32. Global Theraputic Drug Monitorings Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Theraputic Drug Monitorings Revenue Market Share by Application (2025-2030)
    Table 34. North America Theraputic Drug Monitorings Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. North America Theraputic Drug Monitorings Market Size by Country (2019-2024) & (US$ Million)
    Table 36. North America Theraputic Drug Monitorings Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Europe Theraputic Drug Monitorings Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Europe Theraputic Drug Monitorings Market Size by Country (2019-2024) & (US$ Million)
    Table 39. Europe Theraputic Drug Monitorings Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Asia-Pacific Theraputic Drug Monitorings Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Asia-Pacific Theraputic Drug Monitorings Market Size by Region (2019-2024) & (US$ Million)
    Table 42. Asia-Pacific Theraputic Drug Monitorings Market Size by Region (2025-2030) & (US$ Million)
    Table 43. Latin America Theraputic Drug Monitorings Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Latin America Theraputic Drug Monitorings Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Latin America Theraputic Drug Monitorings Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Middle East & Africa Theraputic Drug Monitorings Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 47. Middle East & Africa Theraputic Drug Monitorings Market Size by Country (2019-2024) & (US$ Million)
    Table 48. Middle East & Africa Theraputic Drug Monitorings Market Size by Country (2025-2030) & (US$ Million)
    Table 49. Roche AG Company Detail
    Table 50. Roche AG Business Overview
    Table 51. Roche AG Theraputic Drug Monitorings Product
    Table 52. Roche AG Revenue in Theraputic Drug Monitorings Business (2019-2024) & (US$ Million)
    Table 53. Roche AG Recent Development
    Table 54. Siemens Healthineers Company Detail
    Table 55. Siemens Healthineers Business Overview
    Table 56. Siemens Healthineers Theraputic Drug Monitorings Product
    Table 57. Siemens Healthineers Revenue in Theraputic Drug Monitorings Business (2019-2024) & (US$ Million)
    Table 58. Siemens Healthineers Recent Development
    Table 59. Thermo Fisher Scientific Company Detail
    Table 60. Thermo Fisher Scientific Business Overview
    Table 61. Thermo Fisher Scientific Theraputic Drug Monitorings Product
    Table 62. Thermo Fisher Scientific Revenue in Theraputic Drug Monitorings Business (2019-2024) & (US$ Million)
    Table 63. Thermo Fisher Scientific Recent Development
    Table 64. Beckman Coulter Company Detail
    Table 65. Beckman Coulter Business Overview
    Table 66. Beckman Coulter Theraputic Drug Monitorings Product
    Table 67. Beckman Coulter Revenue in Theraputic Drug Monitorings Business (2019-2024) & (US$ Million)
    Table 68. Beckman Coulter Recent Development
    Table 69. Agilent Technologies Company Detail
    Table 70. Agilent Technologies Business Overview
    Table 71. Agilent Technologies Theraputic Drug Monitorings Product
    Table 72. Agilent Technologies Revenue in Theraputic Drug Monitorings Business (2019-2024) & (US$ Million)
    Table 73. Agilent Technologies Recent Development
    Table 74. BioMérieux Company Detail
    Table 75. BioMérieux Business Overview
    Table 76. BioMérieux Theraputic Drug Monitorings Product
    Table 77. BioMérieux Revenue in Theraputic Drug Monitorings Business (2019-2024) & (US$ Million)
    Table 78. BioMérieux Recent Development
    Table 79. Sekisui Medical Company Detail
    Table 80. Sekisui Medical Business Overview
    Table 81. Sekisui Medical Theraputic Drug Monitorings Product
    Table 82. Sekisui Medical Revenue in Theraputic Drug Monitorings Business (2019-2024) & (US$ Million)
    Table 83. Sekisui Medical Recent Development
    Table 84. DiaSorin Company Detail
    Table 85. DiaSorin Business Overview
    Table 86. DiaSorin Theraputic Drug Monitorings Product
    Table 87. DiaSorin Revenue in Theraputic Drug Monitorings Business (2019-2024) & (US$ Million)
    Table 88. DiaSorin Recent Development
    Table 89. Fujirebio Company Detail
    Table 90. Fujirebio Business Overview
    Table 91. Fujirebio Theraputic Drug Monitorings Product
    Table 92. Fujirebio Revenue in Theraputic Drug Monitorings Business (2019-2024) & (US$ Million)
    Table 93. Fujirebio Recent Development
    Table 94. Grifols Company Detail
    Table 95. Grifols Business Overview
    Table 96. Grifols Theraputic Drug Monitorings Product
    Table 97. Grifols Revenue in Theraputic Drug Monitorings Business (2019-2024) & (US$ Million)
    Table 98. Grifols Recent Development
    Table 99. Ortho-Clinical Diagnostics Company Detail
    Table 100. Ortho-Clinical Diagnostics Business Overview
    Table 101. Ortho-Clinical Diagnostics Theraputic Drug Monitorings Product
    Table 102. Ortho-Clinical Diagnostics Revenue in Theraputic Drug Monitorings Business (2019-2024) & (US$ Million)
    Table 103. Ortho-Clinical Diagnostics Recent Development
    Table 104. Quest Diagnostics Company Detail
    Table 105. Quest Diagnostics Business Overview
    Table 106. Quest Diagnostics Theraputic Drug Monitorings Product
    Table 107. Quest Diagnostics Revenue in Theraputic Drug Monitorings Business (2019-2024) & (US$ Million)
    Table 108. Quest Diagnostics Recent Development
    Table 109. Sysmex Company Detail
    Table 110. Sysmex Business Overview
    Table 111. Sysmex Theraputic Drug Monitorings Product
    Table 112. Sysmex Revenue in Theraputic Drug Monitorings Business (2019-2024) & (US$ Million)
    Table 113. Sysmex Recent Development
    Table 114. Tosoh Company Detail
    Table 115. Tosoh Business Overview
    Table 116. Tosoh Theraputic Drug Monitorings Product
    Table 117. Tosoh Revenue in Theraputic Drug Monitorings Business (2019-2024) & (US$ Million)
    Table 118. Tosoh Recent Development
    Table 119. Chromsystems Company Detail
    Table 120. Chromsystems Business Overview
    Table 121. Chromsystems Theraputic Drug Monitorings Product
    Table 122. Chromsystems Revenue in Theraputic Drug Monitorings Business (2019-2024) & (US$ Million)
    Table 123. Chromsystems Recent Development
    Table 124. Bio-Rad Company Detail
    Table 125. Bio-Rad Business Overview
    Table 126. Bio-Rad Theraputic Drug Monitorings Product
    Table 127. Bio-Rad Revenue in Theraputic Drug Monitorings Business (2019-2024) & (US$ Million)
    Table 128. Bio-Rad Recent Development
    Table 129. R-Biopharm AG Company Detail
    Table 130. R-Biopharm AG Business Overview
    Table 131. R-Biopharm AG Theraputic Drug Monitorings Product
    Table 132. R-Biopharm AG Revenue in Theraputic Drug Monitorings Business (2019-2024) & (US$ Million)
    Table 133. R-Biopharm AG Recent Development
    Table 134. ALPCO Company Detail
    Table 135. ALPCO Business Overview
    Table 136. ALPCO Theraputic Drug Monitorings Product
    Table 137. ALPCO Revenue in Theraputic Drug Monitorings Business (2019-2024) & (US$ Million)
    Table 138. ALPCO Recent Development
    Table 139. BIOHIT Healthcare Company Detail
    Table 140. BIOHIT Healthcare Business Overview
    Table 141. BIOHIT Healthcare Theraputic Drug Monitorings Product
    Table 142. BIOHIT Healthcare Revenue in Theraputic Drug Monitorings Business (2019-2024) & (US$ Million)
    Table 143. BIOHIT Healthcare Recent Development
    Table 144. MedTox Company Detail
    Table 145. MedTox Business Overview
    Table 146. MedTox Theraputic Drug Monitorings Product
    Table 147. MedTox Revenue in Theraputic Drug Monitorings Business (2019-2024) & (US$ Million)
    Table 148. MedTox Recent Development
    Table 149. Wieslab Company Detail
    Table 150. Wieslab Business Overview
    Table 151. Wieslab Theraputic Drug Monitorings Product
    Table 152. Wieslab Revenue in Theraputic Drug Monitorings Business (2019-2024) & (US$ Million)
    Table 153. Wieslab Recent Development
    Table 154. ARK Diagnostics Company Detail
    Table 155. ARK Diagnostics Business Overview
    Table 156. ARK Diagnostics Theraputic Drug Monitorings Product
    Table 157. ARK Diagnostics Revenue in Theraputic Drug Monitorings Business (2019-2024) & (US$ Million)
    Table 158. ARK Diagnostics Recent Development
    Table 159. Probe Scientific Company Detail
    Table 160. Probe Scientific Business Overview
    Table 161. Probe Scientific Theraputic Drug Monitorings Product
    Table 162. Probe Scientific Revenue in Theraputic Drug Monitorings Business (2019-2024) & (US$ Million)
    Table 163. Probe Scientific Recent Development
    Table 164. Omnica Company Detail
    Table 165. Omnica Business Overview
    Table 166. Omnica Theraputic Drug Monitorings Product
    Table 167. Omnica Revenue in Theraputic Drug Monitorings Business (2019-2024) & (US$ Million)
    Table 168. Omnica Recent Development
    Table 169. Research Programs/Design for This Report
    Table 170. Key Data Information from Secondary Sources
    Table 171. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Theraputic Drug Monitorings Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Theraputic Drug Monitorings Market Share by Type: 2023 VS 2030
    Figure 3. Chemiluminescence Immunoassay (CLIA) Features
    Figure 4. Fluorescence Immunoassay (FPIA) Features
    Figure 5. Radioimmunoassay (RIA) Features
    Figure 6. Colorimetric Immunoassay Features
    Figure 7. Other Immunoassays Features
    Figure 8. Global Theraputic Drug Monitorings Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Theraputic Drug Monitorings Market Share by Application: 2023 VS 2030
    Figure 10. Antiepileptic Drugs Case Studies
    Figure 11. Immunosuppressant Case Studies
    Figure 12. Antitumor Drugs Case Studies
    Figure 13. Psychotropic Drugs Case Studies
    Figure 14. Antibiotic Case Studies
    Figure 15. Antifungal Case Studies
    Figure 16. Cardiovascular Drugs Case Studies
    Figure 17. Antiasthmatic Case Studies
    Figure 18. Others Case Studies
    Figure 19. Theraputic Drug Monitorings Report Years Considered
    Figure 20. Global Theraputic Drug Monitorings Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 21. Global Theraputic Drug Monitorings Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 22. Global Theraputic Drug Monitorings Market Share by Region: 2023 VS 2030
    Figure 23. Global Theraputic Drug Monitorings Market Share by Players in 2023
    Figure 24. Global Top Theraputic Drug Monitorings Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Theraputic Drug Monitorings as of 2023)
    Figure 25. The Top 10 and 5 Players Market Share by Theraputic Drug Monitorings Revenue in 2023
    Figure 26. North America Theraputic Drug Monitorings Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. North America Theraputic Drug Monitorings Market Share by Country (2019-2030)
    Figure 28. United States Theraputic Drug Monitorings Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Canada Theraputic Drug Monitorings Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Europe Theraputic Drug Monitorings Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Europe Theraputic Drug Monitorings Market Share by Country (2019-2030)
    Figure 32. Germany Theraputic Drug Monitorings Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. France Theraputic Drug Monitorings Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. U.K. Theraputic Drug Monitorings Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Italy Theraputic Drug Monitorings Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Russia Theraputic Drug Monitorings Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Nordic Countries Theraputic Drug Monitorings Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Asia-Pacific Theraputic Drug Monitorings Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Asia-Pacific Theraputic Drug Monitorings Market Share by Region (2019-2030)
    Figure 40. China Theraputic Drug Monitorings Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Japan Theraputic Drug Monitorings Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Theraputic Drug Monitorings Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Theraputic Drug Monitorings Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. India Theraputic Drug Monitorings Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Australia Theraputic Drug Monitorings Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Latin America Theraputic Drug Monitorings Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Latin America Theraputic Drug Monitorings Market Share by Country (2019-2030)
    Figure 48. Mexico Theraputic Drug Monitorings Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Brazil Theraputic Drug Monitorings Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Middle East & Africa Theraputic Drug Monitorings Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Middle East & Africa Theraputic Drug Monitorings Market Share by Country (2019-2030)
    Figure 52. Turkey Theraputic Drug Monitorings Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Theraputic Drug Monitorings Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Roche AG Revenue Growth Rate in Theraputic Drug Monitorings Business (2019-2024)
    Figure 55. Siemens Healthineers Revenue Growth Rate in Theraputic Drug Monitorings Business (2019-2024)
    Figure 56. Thermo Fisher Scientific Revenue Growth Rate in Theraputic Drug Monitorings Business (2019-2024)
    Figure 57. Beckman Coulter Revenue Growth Rate in Theraputic Drug Monitorings Business (2019-2024)
    Figure 58. Agilent Technologies Revenue Growth Rate in Theraputic Drug Monitorings Business (2019-2024)
    Figure 59. BioMérieux Revenue Growth Rate in Theraputic Drug Monitorings Business (2019-2024)
    Figure 60. Sekisui Medical Revenue Growth Rate in Theraputic Drug Monitorings Business (2019-2024)
    Figure 61. DiaSorin Revenue Growth Rate in Theraputic Drug Monitorings Business (2019-2024)
    Figure 62. Fujirebio Revenue Growth Rate in Theraputic Drug Monitorings Business (2019-2024)
    Figure 63. Grifols Revenue Growth Rate in Theraputic Drug Monitorings Business (2019-2024)
    Figure 64. Ortho-Clinical Diagnostics Revenue Growth Rate in Theraputic Drug Monitorings Business (2019-2024)
    Figure 65. Quest Diagnostics Revenue Growth Rate in Theraputic Drug Monitorings Business (2019-2024)
    Figure 66. Sysmex Revenue Growth Rate in Theraputic Drug Monitorings Business (2019-2024)
    Figure 67. Tosoh Revenue Growth Rate in Theraputic Drug Monitorings Business (2019-2024)
    Figure 68. Chromsystems Revenue Growth Rate in Theraputic Drug Monitorings Business (2019-2024)
    Figure 69. Bio-Rad Revenue Growth Rate in Theraputic Drug Monitorings Business (2019-2024)
    Figure 70. R-Biopharm AG Revenue Growth Rate in Theraputic Drug Monitorings Business (2019-2024)
    Figure 71. ALPCO Revenue Growth Rate in Theraputic Drug Monitorings Business (2019-2024)
    Figure 72. BIOHIT Healthcare Revenue Growth Rate in Theraputic Drug Monitorings Business (2019-2024)
    Figure 73. MedTox Revenue Growth Rate in Theraputic Drug Monitorings Business (2019-2024)
    Figure 74. Wieslab Revenue Growth Rate in Theraputic Drug Monitorings Business (2019-2024)
    Figure 75. ARK Diagnostics Revenue Growth Rate in Theraputic Drug Monitorings Business (2019-2024)
    Figure 76. Probe Scientific Revenue Growth Rate in Theraputic Drug Monitorings Business (2019-2024)
    Figure 77. Omnica Revenue Growth Rate in Theraputic Drug Monitorings Business (2019-2024)
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions